Barclays’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-66
| Closed | – | – | 4658 |
|
|
2019
Q1 | $0 | Hold |
66
| – | – | ﹤0.01% | 4607 |
|
|
2018
Q4 | $0 | Hold |
66
| – | – | ﹤0.01% | 4735 |
|
|
2018
Q3 | $0 | Hold |
66
| – | – | ﹤0.01% | 4699 |
|
|
2018
Q2 | $0 | Sell |
66
-46
| -41% | – | ﹤0.01% | 4640 |
|
|
2018
Q1 | $0 | Sell |
112
-29,548
| -100% | – | ﹤0.01% | 4614 |
|
|
2017
Q4 | $121K | Buy |
29,660
+27,792
| +1,488% | +$113K | ﹤0.01% | 2915 |
|
|
2017
Q3 | $8K | Sell |
1,868
-64,793
| -97% | -$277K | ﹤0.01% | 3529 |
|
|
2017
Q2 | $222K | Buy |
66,661
+19,762
| +42% | +$65.8K | ﹤0.01% | 2391 |
|
|
2017
Q1 | $432K | Buy |
46,899
+6,921
| +17% | +$63.8K | ﹤0.01% | 2039 |
|
|
2016
Q4 | $308K | Sell |
39,978
-44,617
| -53% | -$344K | ﹤0.01% | 2075 |
|
|
2016
Q3 | $966K | Sell |
84,595
-17,338
| -17% | -$198K | ﹤0.01% | 1436 |
|
|
2016
Q2 | $1.25M | Sell |
101,933
-15,604
| -13% | -$192K | ﹤0.01% | 1331 |
|
|
2016
Q1 | $1.18M | Buy |
117,537
+105,972
| +916% | +$1.06M | ﹤0.01% | 1333 |
|
|
2015
Q4 | $254K | Buy |
11,565
+2,456
| +27% | +$53.9K | ﹤0.01% | 1939 |
|
|
2015
Q3 | $146K | Buy |
9,109
+8,703
| +2,144% | +$139K | ﹤0.01% | 2245 |
|
|
2015
Q2 | $9K | Sell |
406
-1,504
| -79% | -$33.3K | ﹤0.01% | 3373 |
|
|
2015
Q1 | $48K | Buy |
1,910
+480
| +34% | +$12.1K | ﹤0.01% | 2768 |
|
|
2014
Q4 | $30K | Sell |
1,430
-1,494
| -51% | -$31.3K | ﹤0.01% | 3262 |
|
|
2014
Q3 | $52K | Sell |
2,924
-4,225
| -59% | -$75.1K | ﹤0.01% | 2985 |
|
|
2014
Q2 | $165K | Buy |
7,149
+2,008
| +39% | +$46.3K | ﹤0.01% | 2484 |
|
|
2014
Q1 | $169K | Buy |
5,141
+4,996
| +3,446% | +$164K | ﹤0.01% | 2467 |
|
|
2013
Q4 | $4K | Sell |
145
-120
| -45% | -$3.31K | ﹤0.01% | 4099 |
|
|
2013
Q3 | $4K | Buy |
+265
| New | +$4K | ﹤0.01% | 3877 |
|